The Cardiovascular Research Foundation's Technology & Heart Failure Therapeutics (THT) 2025 conference will feature multiple late-breaking clinical trials across four dedicated sessions.
TCT 2024 will feature 25 late-breaking clinical trials, presenting novel interventions, drugs, and techniques for cardiovascular disease treatment.
Philips has enrolled the first patient in the DEFINE GPS trial, a global study investigating if iFR measurements co-registered on angiograms improve outcomes in coronary interventions compared to standard angiography alone.